Curis
CRIS
#10206
Rank
S$22.29 M
Marketcap
S$1.72
Share price
-1.48%
Change (1 day)
-68.92%
Change (1 year)

P/E ratio for Curis (CRIS)

P/E ratio as of December 2025 (TTM): -0.3624

According to Curis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.362398. At the end of 2024 the company had a P/E ratio of -0.4353.

P/E ratio history for Curis from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-0.4353-69.21%
2023-1.4157.16%
2022-0.8994-90.55%
2021-9.52-22.12%
2020-12.2597.48%
2019-1.75151.46%
2018-0.6970
2016-6.8417.6%
2015-5.82-18.52%
2014-7.14-62.01%
2013-18.89.62%
2012-17.2-56.03%
2011-39.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Exelixis
EXEL
17.6-4,954.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
8.24-2,374.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-2.86 689.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-8.31 2,193.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
14.7-4,163.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.1-4,805.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-0.5925 63.50%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.